Clinical Trial Update: Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer [Phase 2]

View source ↗

Summary

This report describes an ongoing Phase 2 clinical trial evaluating risk-stratified de-escalated hormone therapy in combination with radiation therapy for prosta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma | Phase 2 | Status: RECRUITING